The results indicated FAT4 mRNA expression decreased in a majority of NSCLC cohorts (25/27) compared to the corresponding non‐tumor lung tissues (NTL), except for two cohorts (GSE20189 and GSE39345) (Table S1). The gene discussed is FAT4; the disease is non-small cell lung carcinoma.